Saint Luke's Episcopal Hospital — Houston, Texas

Saint Luke's Episcopal Hospital is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

Saint Luke's Episcopal Hospital has participated in 7 clinical trials.

Therapeutic areas: Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer, Stage IV Pancreatic Cancer.

Sponsors: National Cancer Institute (NCI), Point Therapeutics, SWOG Cancer Research Network.

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Saint Luke's Episcopal Hospital?

Saint Luke's Episcopal Hospital has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Saint Luke's Episcopal Hospital conducted?

Saint Luke's Episcopal Hospital has 7 clinical trials on record. Their work covers Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer, Stage IV Pancreatic Cancer.

Is Saint Luke's Episcopal Hospital accredited by Crixeo Health?

Yes — Saint Luke's Episcopal Hospital holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Saint Luke's Episcopal Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.